Molecular Mechanisms of Intervertebral Disc Degeneration. 2019

Sean M Rider, and Shuichi Mizuno, and James D Kang
Department of Orthopedic Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Intervertebral disc degeneration is a well-known cause of disability, the result of which includes neck and back pain with associated mobility limitations. The purpose of this article is to provide an overview of the known molecular mechanisms through which intervertebral disc degeneration occurs as a result of complex interactions of exogenous and endogenous stressors. This review will focus on some of the identified molecular changes leading to the deterioration of the extracellular matrix of both the annulus fibrosus and nucleus pulposus. In addition, we will provide a summation of our current knowledge supporting the role of associated DNA and intracellular damage, cellular senescence's catabolic effects, oxidative stress, and the cell's inappropriate response to damage in contributing to intervertebral disc degeneration. Our current understanding of the molecular mechanisms through which intervertebral disc degeneration occurs provides us with abundant insight into how physical and chemical changes exacerbate the degenerative process of the entire spine. Furthermore, we will describe some of the related molecular targets and therapies that may contribute to intervertebral repair and regeneration.

UI MeSH Term Description Entries

Related Publications

Sean M Rider, and Shuichi Mizuno, and James D Kang
January 2017, Journal of head, neck & spine surgery,
Sean M Rider, and Shuichi Mizuno, and James D Kang
June 2016, International journal of molecular medicine,
Sean M Rider, and Shuichi Mizuno, and James D Kang
January 2024, Cells,
Sean M Rider, and Shuichi Mizuno, and James D Kang
January 2012, Advances in experimental medicine and biology,
Sean M Rider, and Shuichi Mizuno, and James D Kang
January 2004, The spine journal : official journal of the North American Spine Society,
Sean M Rider, and Shuichi Mizuno, and James D Kang
May 2024, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
Sean M Rider, and Shuichi Mizuno, and James D Kang
September 2023, Cell proliferation,
Sean M Rider, and Shuichi Mizuno, and James D Kang
January 2024, Frontiers in cell and developmental biology,
Sean M Rider, and Shuichi Mizuno, and James D Kang
June 2023, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
Sean M Rider, and Shuichi Mizuno, and James D Kang
March 2013, The spine journal : official journal of the North American Spine Society,
Copied contents to your clipboard!